ROMA (ITALPRESS) – More than 350 million paybacks paid by companies in out of patent drugs for direct purchases of 2025, despite the prices of these medicines are already under negotiation with Aifa and the subsequent competition in regional public competitions. This is what Egualia points out on the occasion of the editions on the maneuver, asking for a revision of the shelf mechanism that recognizes the specificities of the sector of medicinal products without patent.
“The paradox of the current system is that the enterprises that already contribute to the containment of the expenditure through the races are called to support also an additional levy in order to reinstate the sinking of the total roof of the direct purchases, fed by other factors, not subject to the same competitive dynamics. A mechanism that threatens to compromise the economic sustainability of numerous supplies, reduce the presence of operators on the market and aggravate the difficulties of supplying. A disturbing signal already comes from the hospital races, in which about three out of ten lots go deserted.”.
For this reason the association proposes priority “to exclude from the computation of the roof of expenditure for direct purchases medicinal products purchased through public tender procedures, recognizing that, for these products, competition is already an effective tool of government of expenditure”.
Alternatively, Egualia asks “the elimination of the payback for the patented drugs purchased in the race or, at least, a significant reduction of the shelf share to the expense of the enterprises, through a different distribution of the charges with the Regions. The aim is not to remove the sector from the government of pharmaceutical spending, but to prevent the overlapping of cost containment tools from weakening the competitive market that has allowed the SSN to achieve structural savings. Maintaining an adequate number of suppliers on the market is in fact essential to preserve the savings of the National Health Service and ensure the continuity of care to patients.”.
-Photo IPA Agency-
(ITALPRESS).
